A detailed history of Navellier & Associates Inc transactions in Phibro Animal Health Corp stock. As of the latest transaction made, Navellier & Associates Inc holds 51,626 shares of PAHC stock, worth $2.33 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
51,626
Previous 43,771 17.95%
Holding current value
$2.33 Million
Previous $1.12 Million 86.93%
% of portfolio
0.23%
Previous 0.15%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 06, 2025

BUY
$26.11 - $41.23 $205,094 - $323,861
7,855 Added 17.95%
51,626 $2.09 Million
Q2 2025

Aug 07, 2025

SELL
$16.53 - $25.66 $19,373 - $30,073
-1,172 Reduced 2.61%
43,771 $1.12 Million
Q1 2025

May 06, 2025

BUY
$20.05 - $26.22 $901,107 - $1.18 Million
44,943 New
44,943 $959,000

Others Institutions Holding PAHC

About PHIBRO ANIMAL HEALTH CORP


  • Ticker PAHC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 20,337,600
  • Market Cap $917M
  • Description
  • Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for food and companion animals. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for poultry, swine, beef and dairy c...
More about PAHC
Track This Portfolio

Track Navellier & Associates Inc Portfolio

Follow Navellier & Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Navellier & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Navellier & Associates Inc with notifications on news.